Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells

Arthritis and Rheumatism

Volumn 52, Issue 6, 2005, Pages 1897-1906

  Amirahmadi, S Fatemah ^a   Whittingham, Senga ^a   Crombie, Duncan E ^a   Nandakumar, Kutty Selva ^b   Holmdahl, Rikard ^b   Mackay, Ian R ^a   Van Damme, Marie Paule ^a   Rowley, Merrill J ^a  

^a MONASH UNIVERSITY   (Australia)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; EPITOPE; IMMUNOGLOBULIN SUBCLASS; ISOTOPE; MONOCLONAL ANTIBODY CII; MONOCLONAL ANTIBODY CIIC1; MONOCLONAL ANTIBODY CIIF4; MONOCLONAL ANTIBODY GAD6; MONOCLONAL ANTIBODY M 2139; PROLINE H 3; PROTEOGLYCAN; SULFATE S 35; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTHRITIS; ARTICLE; CARTILAGE; CARTILAGE CELL; CATTLE; CELL CULTURE; CELL STRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; MOUSE; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; SYNTHESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS; BIOLOGICAL MARKERS; CARTILAGE; CHONDROCYTES; COLLAGEN TYPE II; MICE;

EID: 20744447757     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21097     Document Type: Article

References (42)

1. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997;61:1861-78.
2. Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a trangenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994;24:1698-702.
3. Schulte S, Unger C, Mo JA, Wendler O, Bauer E, Frischholz S, et al. Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem 1998;273:1551-61.
4. Amirahmadi SF, Pho MH, Gray RE, Crombie DE, Whittingham SF, Zuasti BB, et al. An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes. Immunol Cell Biol 2004;82:427-34.
5. Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002;46:2339-48.
6. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 1986;29:400-10.
7. Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003;163:1827-37.
8. Chang YC, Gottlieb DI. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 1988;8:2123-30.
9. Davies JM, Rowley MJ, MacKay IR. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen. Immunol Cell Biol 1999;77: 483-90.
10. Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B. Collagen antibodies in rheumatoid arthritis: significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum 1986;29:174-84.
11. Roach HI, Aigner T, Kouri JB. Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis 2004;9:265-77.
12. Gray RE, Seng N, Mackay IR, Rowley MJ. Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. J Immunol Methods 2004;285:55-61.
13. Takagi T, Jasin HE. Interactions between anticollagen antibodies and chondrocytes. Arthritis Rheum 1992;35:224-30.
14. Takagi T, Jasin HE. Interactions of synovial fluid immunoglobulins with chondrocytes. Arthritis Rheum 1992;35:1502-9.
15. Tuckwell DS, Ayad S, Grant ME, Takigawa M, Humphries MJ. Conformation dependence of integrin-type II collagen binding: inability of collagen peptides to support α2β1 binding, and mediation of adhesion to denatured collagen by a novel α5β1-fibronectin bridge. J Cell Sci 1994;107:993-1005.
16. Mansson B, Wenglen C, Morgelin M, Saxne T, Heinegard D. Association of chondroadherin with collagen type II. J Biol Chem 2001;276:32883-8.
17. Muir H. The chondrocyte, architect of cartilage: biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995;17:1039-48.
18. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins α(1)β(1) and α(2)β(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collasens. J Biol Chem 2000; 275:35-40.
19. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285: 1028-32.
20. Pulai JI, del Carlo M Jr, Loeser RF. The α5β1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum 2002;46:1528-35.
21. Fertala A, Sieron AL, Adachi E, Jimenez SA. Collagen II containing a Cys substitution for Arg-α1-519: abnormal interactions of the mutated molecules with collagen IX. Biochemistry 2001;40: 14422-8.
22. Mallein-Gerin F, Ruggiero F. Quinn TM, Bard F, Grodzinsky AJ, Olsen BR, et al. Analysis of collagen synthesis and assembly in culture by immortalized mouse chondrocytes in the presence or absence of α1(IX) collagen chains. Exp Cell Res 1995;219:257-65.
23. Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ, Bruckner P. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 2000;275:10370-8.
24. Maccioni M, Zeder-Lutz G, Huang H, Ebel C, Gerber P, Hergueux J, et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002;195:1071-7.
25. Watson WC, Brown PS, Pitcock JA, Townes AS. Passive transfer Studies with type II collagen antibody in B10.D2/old and new line and C57B1/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum 1987;30: 460-5.
26. Wang Y, Rollins SA, Madri JA, Matis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A 1995;92: 8955-9.
27. Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol 2004;34:1208-16.
28. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcγ receptors. J Exp Med 2000;191:1611-6.
29. Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol 2002;14: 798-802.
30. Nandakumar KS, Andren M, Martinsson P, Bajtner E, Hellstrom S, Holmdahl R, et al. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcγRIIB. Eur J Immunol 2003;33: 2269-77.
31. Diaz de Stahl T, Andren M, Martinsson P, Verbeek JS, Kleinau S. Expression of FcγRIII is required for development of collagen-induced arthritis. Eur J Immunol 2002;32:2915-22.
32. Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 1991;266:5625-8.
33. Tiku K, Thakker-Varia S, Ramachandrula A, Tiku ML. Articular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activity. Cell Immunol 1992;140:1-20.
34. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585-94.
35. Pap T, van der Laan WH, Aupperle KR, Gay RE, Verheijen JH, Firestein GS, et al. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum 2000;43:2531-6.
36. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35:1263-8.
37. Landewe R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1390-9.
38. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996;39:1720-7.
39. Cook AD, Gray R, Ramshaw J, Mackay IR, Rowley MJ. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis. Arthritis Res Ther 2004;6:R477-83.
40. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
41. Kimura H, Tateishi H, Ziff M. Surface ultrastructure of rheumatoid articular cartilage. Arthritis Rheum 1977;20:1085-98.
42. Cenacchi G, Carrabba M, Govoni E, Angelini M, Colombo B, Laschi R. The possible role of collagen fibril dysplasia in the pathogenesis of cartilage damage in rheumatoid arthritis. Clin Exp Rheumatol 1987;5:189-90.